Results 121 to 130 of about 48,965 (195)

Early Combination Antiretroviral Therapy Initiation During Primary HIV Infection Restricts HIV Reservoirs and Gut-Driven Inflammation but Fails to Rewire the Systemic Cytokine Landscape. [PDF]

Open Forum Infect Dis
Bono V, Tincati C, Augello M, Rovito R, Sala V, Gabrieli A, Nozza S, Bruzzesi E, Dispinseri S, Calcagno A, Giacomelli A, Scarlatti G, Bandera A, Muscatello A, Gori A, Rusconi S, Marchetti G.   +16 more
europepmc   +1 more source

HIV Latent Reservoir Cure Strategies [PDF]

iScience Notes, 2016
openaire   +2 more sources

Neuroinflammation, Blood-Brain Barrier, and HIV Reservoirs in the CNS: An In-Depth Exploration of Latency Mechanisms and Emerging Therapeutic Strategies. [PDF]

Viruses
Said N, Venketaraman V.
europepmc   +1 more source

Targeting Latent HIV Reservoirs: Effectiveness of Combination Therapy with HDAC and PARP Inhibitors. [PDF]

Viruses
Tibebe H, Marquez D, McGraw A, Gagliardi S, Sullivan C, Hillmer G, Narayan K, Izumi C, Keating A, Izumi T.   +9 more
europepmc   +1 more source

The Glutamate System as a Crucial Regulator of CNS Toxicity and Survival of HIV Reservoirs. [PDF]

Front Cell Infect Microbiol, 2020
Gorska AM, Eugenin EA.
europepmc   +1 more source

Timing of antiretroviral therapy initiation affects intact HIV reservoirs following analytical treatment interruption. [PDF]

J Clin Invest
Manning MR, Blazkova J, Justement JS, Shi V, Kennedy BD, Rai MA, Seamon CA, Gittens K, Sneller MC, Moir S, Chun TW.   +10 more
europepmc   +1 more source

Harnessing immune cells to eliminate HIV reservoirs. [PDF]

Curr Opin HIV AIDS
Grasberger P, Sondrini AR, Clayton KL.
europepmc   +1 more source

Selective decline of intact HIV reservoirs during the first decade of ART followed by stabilization in memory T cell subsets. [PDF]

AIDS
Nühn MM, Bosman K, Huisman T, Staring WHA, Gharu L, De Jong D, De Kort TM, Buchholtz NVEJ, Tesselaar K, Pandit A, Arends J, Otto SA, Lucio De Esesarte E, Hoepelman AIM, De Boer RJ, Symons J, Borghans JAM, Wensing AMJ, Nijhuis M.   +18 more
europepmc   +1 more source

BCL-2 antagonism sensitizes cytotoxic T cell-resistant HIV reservoirs to elimination ex vivo. [PDF]

J Clin Invest, 2020
Ren Y, Huang SH, Patel S, Alberto WDC, Magat D, Ahimovic D, Macedo AB, Durga R, Chan D, Zale E, Mota TM, Truong R, Rohwetter T, McCann CD, Kovacs CM, Benko E, Wimpelberg A, Cannon C, Hardy WD, Bosque A, Bollard CM, Jones RB.   +21 more
europepmc   +1 more source

Bivalent SMAC mimetic APG-1387 reduces HIV reservoirs and limits viral rebound in humanized mice. [PDF]

iScience
Jain J, Pham TNQ, Begum S, Romero-Medina MC, Bellini N, Li Y, Dallaire F, Béland K, Patey N, Guimond JV, Haddad É, Zhai Y, Cohen ÉA.   +12 more
europepmc   +1 more source